Not for human use, for research purposes only
Shipping update: orders placed before Friday, Oct 16, 10:30 AM (Bangkok time) are dispatched that day. Orders placed after that are dispatched on Thursday, Oct 22.
July 6, 2026 3 min read Research Guides

KLOW vs Glow 70: Comparing Two Multi-Peptide Research Blends

KLOW and Glow 70 are both multi-peptide research blends built on the same three-peptide core. The difference comes down to one component. Here is how they compare.

By Milo-Lab Research Team

KLOW and Glow 70 are both multi-peptide research blends, and they are far closer to each other than most blend pairings. Both are built on the same three-peptide core; KLOW adds a fourth component. Below is a mechanistic, side-by-side look at both.

The Shared Core: BPC-157, TB-500 and GHK-Cu

Both blends are built on the same three peptides, in the same amounts:

  • BPC-157 (10mg): a stable pentadecapeptide based on a sequence found in human gastric juice. It is studied for upregulating VEGF and VEGFR2 expression and for activating FAK-paxillin signalling in fibroblast cell models.
  • TB-500 (10mg): a synthetic fragment of thymosin beta-4. By binding free G-actin it regulates actin polymerisation, which is studied in cell-migration assays.
  • GHK-Cu (50mg): the copper tripeptide and the largest component of both blends by mass. In fibroblast models it is reported to influence expression of collagen types I, III and VI and decorin, to release VEGF and FGF, and to act as an antioxidant and gene-expression modulator.

The three components cover distinct signalling nodes: VEGF and FAK-paxillin signalling (BPC-157), actin regulation (TB-500) and copper-peptide gene-expression modulation (GHK-Cu).

What KLOW Adds: KPV

KLOW is supplied as a single 80mg vial: BPC-157 10mg · TB-500 10mg · KPV 10mg · GHK-Cu 50mg. The additional component is KPV, the C-terminal tripeptide (Lys-Pro-Val) of alpha-MSH. It is studied for the anti-inflammatory and immune-modulating signalling of the parent hormone, without its pigmentary activity. Full component breakdown is on the KLOW product page.

What Glow 70 Is: The Core Without KPV

Glow 70 is a single 70mg vial: BPC-157 10mg · TB-500 10mg · GHK-Cu 50mg. It is the same core as KLOW with the KPV component removed, which makes it the simpler of the two. GHK-Cu accounts for 50 of the 70mg, a larger mass share than in KLOW. Full component detail is on the Glow 70 product page.

Comparison Table

KLOWGlow 70
Vial size80mg70mg
BPC-15710mg10mg
TB-50010mg10mg
GHK-Cu50mg50mg
KPV10mgNot included
GHK-Cu mass per vial50 of 80mg50 of 70mg

Where the Two Overlap

The overlap is the blend, not just a shared ingredient: BPC-157, TB-500 and GHK-Cu appear in identical amounts in both. Every component of Glow 70 is also present in KLOW.

The single compositional difference is KPV, which is present at 10mg in KLOW and absent from Glow 70.

Comparing More Than Two Products

For a broader side-by-side across the full product catalog, including specification and mechanism comparisons beyond these two blends, see the compare tool.

Research Use Only

Both KLOW and Glow 70 are supplied strictly for laboratory and research use. This article does not describe a treatment, does not claim any outcome, and is not medical advice. Component-level study citations are available on the respective linked product pages. For research purposes only. Not for human consumption.

klow glow-70 peptide-blends blend-composition

Interested in the peptides discussed in this article?

Browse our full catalog of research-grade peptides or contact us with questions about product specifications.